These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25818412)

  • 21. Self-Emulsifying Drug Delivery System of Celecoxib for Avoiding Delayed Oral Absorption in Rats with Impaired Gastric Motility.
    Yakushiji K; Sato H; Ogino M; Suzuki H; Seto Y; Onoue S
    AAPS PharmSciTech; 2020 May; 21(5):135. PubMed ID: 32419073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo pharmacokinetics of celecoxib loaded endcapped PCLA-PEG-PCLA thermogels in rats after subcutaneous administration.
    van Midwoud PM; Sandker M; Hennink WE; de Leede LGJ; Chan A; Weinans H
    Eur J Pharm Biopharm; 2018 Oct; 131():170-177. PubMed ID: 30075312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths.
    Zhang Y; Che E; Zhang M; Sun B; Gao J; Han J; Song Y
    Int J Pharm; 2014 Oct; 473(1-2):375-83. PubMed ID: 25051114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional porous silicon for therapeutic drug delivery and imaging.
    Santos HA; Bimbo LM; Lehto VP; Airaksinen AJ; Salonen J; Hirvonen J
    Curr Drug Discov Technol; 2011 Sep; 8(3):228-49. PubMed ID: 21291407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluation.
    Nguyen TH; Tan A; Santos L; Ngo D; Edwards GA; Porter CJ; Prestidge CA; Boyd BJ
    J Control Release; 2013 Apr; 167(1):85-91. PubMed ID: 23353808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS.
    Lainé AL; Price D; Davis J; Roberts D; Hudson R; Back K; Bungay P; Flanagan N
    Int J Pharm; 2016 Oct; 512(1):118-125. PubMed ID: 27543354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.
    Araújo F; Shrestha N; Shahbazi MA; Fonte P; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Santos HA; Sarmento B
    Biomaterials; 2014 Nov; 35(33):9199-207. PubMed ID: 25109441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles.
    Bimbo LM; Mäkilä E; Raula J; Laaksonen T; Laaksonen P; Strommer K; Kauppinen EI; Salonen J; Linder MB; Hirvonen J; Santos HA
    Biomaterials; 2011 Dec; 32(34):9089-99. PubMed ID: 21864895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supersaturation of poorly soluble drugs induced by mesoporous magnesium carbonate.
    Zhang P; Zardán Gómez de la Torre T; Welch K; Bergström C; Strømme M
    Eur J Pharm Sci; 2016 Oct; 93():468-74. PubMed ID: 27590126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study.
    Zhao P; Wang L; Sun C; Jiang T; Zhang J; Zhang Q; Sun J; Deng Y; Wang S
    Eur J Pharm Biopharm; 2012 Apr; 80(3):535-43. PubMed ID: 22193360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs.
    Wang F; Hui H; Barnes TJ; Barnett C; Prestidge CA
    Mol Pharm; 2010 Feb; 7(1):227-36. PubMed ID: 19874003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs.
    Salonen J; Laitinen L; Kaukonen AM; Tuura J; Björkqvist M; Heikkilä T; Vähä-Heikkilä K; Hirvonen J; Lehto VP
    J Control Release; 2005 Nov; 108(2-3):362-74. PubMed ID: 16169628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
    Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
    Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
    Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
    Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of novel porous starch microsphere foam for loading and release of poorly water soluble drug.
    Jiang T; Wu C; Gao Y; Zhu W; Wan L; Wang Z; Wang S
    Drug Dev Ind Pharm; 2014 Feb; 40(2):252-9. PubMed ID: 23391363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular interactions of surface modified nanoporous silicon particles.
    Bimbo LM; Sarparanta M; Mäkilä E; Laaksonen T; Laaksonen P; Salonen J; Linder MB; Hirvonen J; Airaksinen AJ; Santos HA
    Nanoscale; 2012 May; 4(10):3184-92. PubMed ID: 22508528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.
    Nasr M
    AAPS PharmSciTech; 2013 Jun; 14(2):719-26. PubMed ID: 23543607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pore size of three-dimensionally ordered macroporous chitosan-silica matrix on solubility, drug release, and oral bioavailability of loaded-nimodipine.
    Gao Y; Xie Y; Sun H; Zhao Q; Zheng X; Wang S; Jiang T
    Drug Dev Ind Pharm; 2016; 42(3):464-72. PubMed ID: 26507935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.